Alaunos Therapeutics, Inc.

TCRT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$1,091$6,062$39,058$76,054
Short-Term Investments$0$0$0$0
Receivables$5$1$4$1,111
Inventory$0$0$13,938$0
Other Curr. Assets$1,659$2,198$799$1,666
Total Curr. Assets$2,755$8,261$53,799$78,831
Property Plant & Equip (Net)$0$2$10,596$15,361
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$0$0$542$673
Total NC Assets$0$2$11,138$16,034
Other Assets$0$0$0$0
Total Assets$2,755$8,263$64,937$94,865
Liabilities
Payables$516$616$1,389$1,368
Short-Term Debt$0$0$17,881$9,326
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$176$1,340$4,896$5,347
Total Curr. Liab.$692$1,956$24,166$16,041
LT Debt$0$0$2,188$20,768
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$28-$1
Total NC Liab.$0$0$2,216$20,767
Other Liabilities$0$0$0$0
Cap. Leases$0$0$2,746$5,247
Total Liabilities$692$1,956$26,382$36,808
Equity
Pref Stock$0$0$0$0
Common Stock$2$16$240$216
Retained Earnings-$920,446-$915,767-$880,627-$842,852
AOCI$0$0$0$0
Other Equity$922,507$922,058$918,942$900,693
Total Equity$2,063$6,307$38,555$58,057
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$2,755$8,263$64,937$94,865
Net Debt-$1,091-$6,062-$18,989-$45,960